Growth trajectories of the human fetal brain in healthy and complicated pregnancies and associations with neurodevelopmental outcome in the early life course by Welling, M.S. et al.
Contents lists available at ScienceDirect 
Early Human Development 
journal homepage: www.elsevier.com/locate/earlhumdev 
Growth trajectories of the human fetal brain in healthy and complicated 
pregnancies and associations with neurodevelopmental outcome in the early 
life course 
Mila S. Wellinga, Sofie C. Husena, Attie T.J.I. Goa, Irene A.L. Groenenberga, Sten P. Willemsena,b,  
Hilmar H. Bijmaa, Régine P.M. Steegers-Theunissena,c,⁎ 
a Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Center, 3000, CA, Rotterdam, the Netherlands 
b Department of Biostatistics, Erasmus MC, University Medical Center, 3000, CA, Rotterdam, the Netherlands 
c Department of Pediatrics, Division of Neonatology, Sophia Children's Hospital, 3000, CA, Rotterdam, the Netherlands  
A R T I C L E  I N F O   
Keywords: 





A B S T R A C T   
Background: There is a need for non-invasive prenatal markers of the brain to assess fetuses at risk for poor 
postnatal neurodevelopmental outcome. Periconceptional maternal conditions and pregnancy complications 
impact prenatal brain development. 
Aims: To investigate associations between growth trajectories of fetal brain structures and neurodevelopmental 
outcome in children in the early life course. 
Study design: Periconceptional prospective observational cohort. 
Subjects: Singleton pregnancies were included in the Rotterdam periconception cohort. Two- and three-di-
mensional ultrasound scans at 22, 26 and 32 weeks gestational age were analysed. 
Outcome measures: Head circumference (HC), cerebellum, corpus callosum (CC), Sylvian fissure, insula and 
parieto-occipital fissure (POF) were measured. Neurodevelopment was evaluated using the Age-and-Stages- 
questionnaire-3 (ASQ-3) and the Child-Behaviour-Checklist (CBCL) at 2 years of age. Linear mixed models, used 
to estimate the prenatal brain growth trajectories, and linear regression models, used to evaluate the associations 
between prenatal brain structures and neurodevelopmental outcomes, were applied in the total study popula-
tion, and in subgroups: fetal growth restriction (FGR), preterm birth (PTB), fetal congenital heart disease (CHD), 
and uncomplicated controls. 
Results: Consent for participation was received from parents on behalf of their child 138/203 (68%). ASQ-3 was 
completed in 128/203 children (63%) and CBCL in 93/203 children (46%). Significant smaller subject-specific 
growth trajectories (growth rate of CC, HC, left insula, left POF and right POF and the baseline size of CC, HC, 
left POF and right POF) were found in the FGR subgroup, compared to the other subgroups (all p-values < 0.05). 
In the total group (n = 138), the growth rate of the left insula was associated with poorer ASQ-3 score 
(β = −869.51; p  <  0.05). Healthy controls (n = 106) showed a comparable association (β = −1209.87; 
p  <  0.01). FGR (n = 10) showed a larger baseline size of the right Sylvian fissure in association with poorer 
CBCL-score (β = 4.13; p  <  0.01). In CHD (n = 12) the baseline size of the left Sylvian fissure and its growth 
rate were associated with respectively poorer and better CBCL-scores (β = 3.11; p  <  0.01); (β = −171.99; 
p  <  0.01). In PTB (n = 10) no associations were found. 
Conclusions: This explorative study suggests associations between ultrasound measurements of fetal brain 
growth and neurodevelopmental outcome at 2 years of age. In future, this non-invasive technique may improve 
early identification of fetuses at risk for neurodevelopmental outcome and follow-up postnatal clinical care.   
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Accumulating evidence from non-invasive cerebral ultrasound 
measurements applied in pregnancy show a fetal and even embryonic 
origin of abnormal brain development [1–9] Periconceptional and 
prenatal factors are involved in the growth and development of organs, 
including the brain in second and third trimester of pregnancy [10–12]. 
These factors do not only affect fetal development and brain growth, 
but also neurodevelopment in later life [13–15]. This is in line with the 
paradigm ‘Developmental Origins of Health and Disease’ (DOHaD) 
postulating that an adverse fetal environment leads to developmental 
adaptations that permanently program organ structures, physiology 
and metabolism [16]. 
Cortical folding is an important process in prenatal brain develop-
ment, starting at around 18 weeks of gestation age (GA). During this 
complex process the cerebral surface transforms from a smooth surface 
to the irregular system of sulci and gyri [17]. Deviations in cortical 
folding may be related to pathological cortical functioning. For ex-
ample, studies have shown that brain growth and cortical folding are 
affected by medical conditions influencing the fetal environment, like 
fetal growth restriction (FGR), congenital heart defects (CHD) and 
prematurity [4,6,8]. 
In fetuses with CHD, prenatal brain abnormalities on a tissue level 
are often observed, like white matter injuries, reduced brain volume, 
delay in brain maturation, and altered brain circulation [3,5,7]. In 
addition, structural brain abnormalities in CHD that have been reported 
are ventriculomegaly, vermian hypoplasia, corpus callosum agenesis, 
and cerebellar hypoplasia [5]. Moreover, small deviations in trajec-
tories of cortical folding, e.g. left insula and right POF, have been re-
ported [6]. Also in FGR, it has been postulated that placental in-
sufficiency, leading to chronic hypoxia and undernutrition, may lead to 
abnormal brain development. For example, MRI studies have shown a 
reduction in cortical grey matter and alterations in the gyrification and 
sulcation [1,2,9]. In preterm born children (PTB), disturbances in ax-
onal and neuronal development and injury to the developing white 
matter can lead to multiple brain abnormalities, e.g. interruptions of 
thalamocortical, corticothalamic and cortico-cortical connections and 
decrease in cortical and deep nuclear grey matter volumes [8]. These 
abnormalities can result from an adverse fetal environment, like hy-
poxia-ischemia, infection, or chronic inflammation [18]. 
Both FGR and CHD are developmental abnormalities, that have a 
life-long health impact and may lead to impaired neurodevelopment 
[19–23]. Neurodevelopment outcomes can be assessed using the Ages- 
and-Stages questionnaire (ASQ), in which psychological and locomotive 
neurodevelopment are evaluated, and the Childhood Behaviour 
Checklist (CBCL), in which behavioural and emotional characteristics 
are evaluated. These validated parental report questionnaires are easy 
in use, little time consuming, have low costs and are easy to interpret 
[24,25]. 
Studies reporting on neurodevelopmental outcome in FGR reveal 
adverse motor, cognitive and behaviour outcome [19–21]. In CHD, the 
reported prevalence of internalizing problems (anxiety, depression, 
withdrawal, somatization) and externalizing problems (attention, ag-
gression) ranges for both between 15 and 25% [23]. However, the 
psychomotor development seems more affected than the mental de-
velopment [22]. Multiple studies report on neurodevelopmental out-
come, using the ASQ, in PTB children. They show a large proportion of 
children (36.2–50.2%, depending on the GA at birth) below the ASQ 
threshold, especially for the communication and personal-social do-
mains, and are therefore considered at risk of developmental delay 
[26,27]. 
We hypothesize that specific measurements of structures of prenatal 
fetal brain and its trajectories are associated with neurodevelopmental 
outcome in the early life course up until 2 years of age. In search for a 
non-invasive marker for postnatal neurodevelopmental outcome, and to 
be able to identify fetuses at risk for poorer neurodevelopmental 
outcome, this explorative study aims to evaluate associations between 
growth trajectories of several structures of the human fetal brain and 
neurodevelopment during the early life course, which we define as a 
timespan from preconception up until the age of 2 years, using the ASQ 
-3 and CBCL. Having available a biological marker of altered clinical 
neurodevelopment already during the intra-uterine period, will greatly 
increase the understanding of the impact of prenatal factors on neu-
rodevelopment. This increased knowledge can guide clinical manage-
ment and preconception and pregnancy counseling of the individual 
parents. The secondary aim of this study is to elucidate whether fetuses 
prenatally exposed to maternal pregnancy complications, such as utero- 
placental insufficiency or CHD, are at risk of impaired postnatal neu-
rodevelopmental functioning. This would warrant more attention in 
clinical practice regarding brain development in these children. 
2. Methods 
2.1. Subjects 
The DREAM-study is embedded in the Rotterdam Periconceptional 
Cohort (Predict Study), an ongoing hospital-based open birth cohort 
study at the Erasmus MC, University Medical Centre, Rotterdam, The 
Netherlands [28], investigating periconceptional influences on pla-
cental, embryonic and fetal growth, and maternal pregnancy outcomes. 
From June 2013, pregnant women participating in the Predict Study 
were asked to also participate in the DREAM-study, which entailed 
three additional three-dimensional ultrasound (3D-US) examinations of 
the fetal brain during pregnancy at 22, 26 and 32 weeks gestational age 
(GA). The total cohort consists of children (n = 227), born with com-
plications (e.g. FGR, n = 22; PTB, n = 16; CHD, n = 20) and without 
these complications (healthy controls, n = 155). FGR was defined as an 
abdominal circumference (AC) < p5 or an estimated fetal weight 
(EFW) < p5. PTB was defined as a delivery before 37 weeks of GA. 
When fetuses were both growth restricted and PTB, they were assigned 
to the FGR group. The prematurity of children in the FGR group was 
considered as the iatrogenic consequence of the growth restriction and 
thus secondary to the growth restriction. All parents of the living 
children, whose mother had participated in the DREAM-study, were 
approached and asked to participate with their child in this follow-up 
study at the age of 24 months ± 3 months (corrected for GA at birth). 
Exclusion criteria of the child were confirmed brain abnormalities and 
Down syndrome. All participants received advanced structural ultra-
sound scanning and were only included if there were no structural brain 
abnormalities visible on the fetal ultrasound. Furthermore, children 
were excluded when parents reported a structural brain abnormality or 
when parents reported major events concerning brain development or 
brain damage. Finally, to validate the selection of the study group, 
hospital records of the child were checked by the researcher. All parents 
gave written informed consent before participation of their child. The 
Central Committee of Human Research in the Hague and the regional 
Medical Ethical and Institutional Review Board of the Erasmus MC 
University Medical Centre approved the study (MEC-2016-177, 4 April 
2016). 
2.2. Ultrasound measurements 
The 2D- and 3D-US were performed on the Voluson E8 system (GE 
Medical Systems, Zipf, Austria) using a 1–7 MHz transabdominal 
transducer or a 6–12 MHz transvaginal transducer. Biometric mea-
surements of the head and brain structures were obtained including 
total cerebellar diameter (TCD) and head circumference (HC) using 2D- 
US. These fetal brain structures were measured according to the ISUOG 
guidelines [29,30]. The corpus callosum (CC), left and right Sylvian, 
insula and parieto-occipital fissure (POF) depth measurements were 
performed offline using specialized 3D software (4D View, version 5.0, 
GE Medical Systems) [6]. This software enables to upload the 
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performed 3D-ultrasound volumes offline and manually adjust planes in 
three-dimensions (sectional planes). The volumes were edited manually 
by the operator, ensuring a perfectly corrected plane for the measure-
ments. All brain fissure depth measurements were performed perpen-
dicular to the midline of the brain. First, a mid-baseline was drawn as a 
reference line to optimize precision. Second, the insula and Sylvian 
fissure depth measurements were performed perpendicular to the 
midline of the brain, in the standard axial transventricular plane just 
above the trans-thalamic plane used for biparietal diameter (BPD) and 
HC measurements, according to the ISUOG guidelines [30]. Thirdly, in 
an axial plane slightly above this transventricular plane, slightly rotated 
along the z-axis, the POF measurement was performed perpendicular to 
the midline of the brain, with the cavum septum pellucidum as a re-
ference point. Reorientation of the 3D-US image according to a stan-
dard approach ensured left/right differentiation and optimizes preci-
sion of the measurements. To enhance precision of the measurements a 
certified ultrasonographer carried out all ultrasounds and a researcher 
was trained according to protocol and performed all offline measure-
ments. 
2.3. Follow up study procedures and outcomes 
Psychological and locomotive neurodevelopment was measured 
using the Ages and Stages Questionnaire-3 (ASQ-3). This questionnaire 
is a validated parental questionnaire evaluating milestones in devel-
opment [24]. The ASQ-3 includes five domains (communication, gross 
motor, fine motor, problem solving ability and personal-social skills), 
each measured by six questions. Parents were asked to evaluate whe-
ther their child has achieved a milestone (yes, 10 points), has partly 
achieved a milestone (partly, 5 points) or has not yet achieved a 
milestone (no, 0 points). If a question was not answered the mean score 
of that domain was imputed. If more than two items in a section were 
left blank, the questionnaire was excluded from analysis. All points in 
one domain were added to calculate area scores, which could range 
from 0 to 60 points. The total ASQ-3 score was calculated by summing 
all the area scores (0–300 points), only total score was used as proxy for 
overall development in further analysis. A high ASQ-3 score indicates 
decent developmental progress. 
Behavioural development was evaluated using the preschool version 
of the Child Behaviour Check-list (CBCL), which is a validated parent- 
completed questionnaire assessing the child's abilities and behavioural 
and emotional characteristics [25]. The questionnaire consists of 99 
statements; for each statement the parent evaluates if for their child the 
statement is true (2 points), somewhat or sometimes true (1 point) or 
not true (0 points). These points were added to a Total Problems score 
(CBCL sum score), ranging between 0 and 198 points, which can be 
used to compare behavioural problems in different groups. The CBCL 
sum score was used as proxy for behavioural development in further 
analyses. A high CBCL sum score indicates behavioural and/or emo-
tional problems which suggests poor development. 
Due to logistics, parents were first asked to complete the Ages and 
Stages questionnaire during a hospital visit. Afterwards the Childhood 
Behaviour Check-list was given to them to fill in at home and sent back 
when completed. 
2.4. Statistical analysis 
All statistical analyses were performed using SPSS 21.0 (SPSS for 
Windows, SPSS Inc., Chicago, Illinois, USA) and RStudio 3.4.0 (RStudio: 
Integrated Development for R. RStudio, Inc., Boston, MA). All statistical 
tests were 2-tailed with the significance level set at 0.05. No adjust-
ments were made for multiple testing because the aim of this study was 
explorative and hypotheses-generating [31]. General characteristics 
were calculated for all children. Normal continuous data was compared 
using oneway-ANOVA. Non-normal, continuous data was compared 
using Kruskal-Wallis tests. Categorical data were compared using 
Pearson's Chi-squared tests. All continuous data are expressed as med-
ians with interquartile ranges, all categorical data are expressed as 
numbers and percentages. 
First, linear mixed models were used to analyse the longitudinal 
brain growth data to estimate the growth trajectories of the fetal brain 
structures, taking into account the correlation between the repeated 
measurements. The advantage of linear mixed model is that this tech-
nique allows for use of measurements at other scanning periods to 
approximate the brain structure size for missing ultrasound measure-
ments. In this model, GA and the quadratic term of GA were used as 
predictors. In the analyses the differences between the subjects are es-
timated, leading to a variance for the intercept and slope. For every 
subject, a subject-specific intercepts, called random intercept (RI), and 
a subject-specific coefficients of GA, called random slope (RS), were 
calculated. Because we placed the start of the GA scale at around 
22 weeks, RI can be interpreted as the baseline and relative size of the 
brain structure at 22 weeks GA. For the brain fissures, an increased 
baseline size refers to an increased fissure depth. RS should be inter-
preted as the growth rate of the specific brain structure. RI and RS for 
the brain structures were compared between the groups using one-way 
ANOVA or Kruskal-Wallis tests, followed by respectively Tukey and 
Dunn-Bonferroni Post Hoc tests. Afterwards, the association between 
prenatal brain structures and neurodevelopmental outcomes in linear 
regression models were assessed with the random effects as a predictor 
and neurodevelopmental outcomes as the response. In order to obtain 
the differences in outcome in the ASQ-3 and CBCL large coefficients 
may be expected in the linear regression calculation. The CBCL sum 
score and total ASQ-3 score were studied as continuous outcomes. To 
approximate a normal distribution, the CBCL sum score was square root 
transformed. 
The analyses were done for the total group and all the subgroups 
separately (FGR, PTB, CHD and controls). Adjustment for confounders 
could only be done in the total and control group, because of the limited 
sample sizes of the case groups. The confounders were selected be-
forehand, based on literature and expert knowledge; these comprise 
maternal level of education, parity, mode of conception, periconcep-
tional smoking, preconceptional folic acid supplement use, and gender 
of the child [10]. 
3. Results 
Of 227 children enrolled, 213 survived up to 2 years of age. 10 
children were excluded, because of brain abnormalities diagnosed and 
confirmed using neuroimaging [8] and Down syndrome [2]. This re-
sulted in 203 children eligible for neurodevelopmental evaluation 
(Fig. 1). Consent for participation was received from parents on behalf 
of their child 138/203 (68%). ASQ-3 was completed in 128/203 chil-
dren (63%) and CBCL in 93/203 children (46%). The main baseline 
characteristics of children and their mothers during follow-up com-
pared with those lost to follow-up are presented in supplemental Table 
A. Maternal geographic background, maternal education, and mode of 
conception were significantly different between the mothers of parti-
cipating children and those lost to follow-up. The mothers of the re-
cruited children had more often a Dutch background, were higher 
educated and the children were more often conceived after IVF or ICSI 
treatment. Table 1 shows the baseline characteristics of the children 
and their mothers for all groups. Neurodevelopment was evaluated at a 
median corrected age of 24.4 months (interquartile range, 
24.2–24.7 months). The Kruskal-Wallis H test showed a significantly 
lower GA and birthweight at birth in the FGR and PTB group, compared 
to the CHD and control group, which is inherent to these outcomes. 
There were no other significant differences between the different sub-
groups and controls. 
Supplemental Table C reports the number of ultrasound measure-
ments made per scanning period in total group and subgroups. Table 2 
shows subject-specific growth profiles of the fetal brain structures for 
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on forehand selected brain structures for all subgroups. Significant 
differences were found between the subgroups in growth rate of CC, 
HC, left insula, left POF and right POF (p-values respectively 0.0001, 
0.0001, 0.023, 0.005 and 0.002), and baseline size of CC, HC, left POF 
and right POF (p-values respectively 0.001, 0.0001, 0.009 and 0.007). 
The post hoc tests showed that this all was due to smaller brain growth 
trajectories in FGR subgroup compared to the other subgroups (FGR vs 
CHD, FGR vs PTB and FGR vs Controls, supplemental Table D and E). 
Table 3 shows the total ASQ-3 score and CBCL scores for all sub-
groups. Total ASQ-3 scores were not significantly different between the 
groups (Table 3). In the total group a significant association was ob-
served between the growth rate of the left insula and the ASQ-3 
(β = −869.51, p = 0.027). A similar significant association was seen 
in the healthy controls group (β = −1209.87, p = 0.005) (Table 4). 
There were no significant differences in total CBCL score between 
all groups (Table 3). In the FGR subgroup a significant association was 
observed between the baseline size of the right Sylvian fissure at around 
22 weeks GA and the CBCL (β = 4.13, p = 0.009). In the CHD subgroup 
a significant association was established between the baseline size of 
the left Sylvian fissure at around 22 weeks GA and the CBCL (β = 3.11, 
p = 0.003) and growth rate of the left Sylvian fissure and the CBCL 
(β = −171.99, p = 0.003) (Table 5). 
4. Discussion 
In this prospective cohort study, serial measurements of several 
structures of fetal brain development in the second half of pregnancy 
were studied in association with subsequent neurodevelopment at 
2 years of age in children with FGR, PTB, or CHD and uncomplicated 
controls. Prior to investigating associations, comparisons between 
groups in brain measurements and outcomes measures were performed. 
Comparisons in brain measurements showed significantly smaller and/ 
or slower brain growth trajectories in the FGR subgroup compared with 
the other groups. Overall neurodevelopmental outcomes were not sig-
nificantly different between the groups. Investigation of the associa-
tions showed the following results: in the total group an association was 
seen between the growth rate of the left insula and poorer outcome of 
the ASQ-3 score. In the control group a similar association was estab-
lished between the growth rate of the left insula and poorer outcome of 
the ASQ-3 score. In the FGR subgroup an association was observed 
between the baseline size of the right Sylvian fissure at around 
22 weeks GA and poorer outcome of the CBCL score. No significant 
associations were observed between fetal brain trajectories and neu-
rodevelopmental outcomes in the PTB group. However, in the CHD 
subgroup an association was observed between the baseline size of the 
left Sylvian fissure at around 22 weeks GA and a poorer outcome of the 
CBCL score and an association between the growth rate of the left 
Sylvian fissure and a better CBCL score. 
In the second half of pregnancy, fetal brain growth trajectories were 
different across the groups. The FGR subgroup showed already sig-
nificantly smaller baseline brain structures at around 22 weeks GA and 
smaller growth rates of CC, HC, left insula and left and right POF, when 
compared with the other groups. These smaller growth rates could be 
explained by the general growth restriction and reported brain ab-
normalities in fetuses with FGR due to chronic hypoxia and under-
nutrition [1,2,9]. 
Some of these smaller and/or slower brain growth trajectories were 
also found in the PTB and CHD subgroups. In CHD, only the baseline 
Fig. 1. Flowchart of follow-up Cohort.  
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size of CC was evidently smaller. No literature to date, report on the 
prenatal size of CC in fetuses with CHD. Multiple studies show de-
creased prenatal head circumference in CHD [3]; also in this study a 
slower growth rate of HC was seen, however baseline size was bigger in 
this subgroup. In the PTB group a smaller baseline size of the right 
Sylvian fissure was seen. Several studies, report on chronic inflamma-
tion being involved in PTB, also affecting prenatal brain growth causing 
brain injury and developmental abnormalities [18,32]. 
Previous studies have reported on neurodevelopmental delays in 
children with FGR, PTB, and CHD [19–23,27]. Pierrat et al. studied a 
large cohort of 2506 PTB children and found developmental delays, 
also measured with ASQ, in children who are born before 35 weeks' 
gestation [27]. Children with a history of FGR are reported to be at high 
risk of developing neurobehavioral and neurocognitive deficits 
[19–21]. In children with CHD abnormal neurologic examinations and 
gross and fine motor abnormalities have been described [22,23]. In our 
study, however, no differences in various domains of neurodevelop-
ment were found between cases and controls. 
The results of this explorative study suggest that differences in 
gyrification of the insula and Sylvian fissure in both control group and 
subgroups is associated with neurodevelopmental outcome. Firstly, a 
significant association between a higher growth rate of the left insula 
and lower outcome of the ASQ-3 in the total and controls group was 
seen. Though before cortical folding was thought to be driven me-
chanically by expansion of the brain, literature to date shows that ab-
normal cortical folding reflects underlying microstructural changes in 
the formation, migration and differentiation of neuronal cells. Matsuda 
et al. states that underlying intracortical axonal connections can influ-
ence cortical gyrification. This mechanical tension hypothesis states 
that cortical regions with greater neural connectivity are associated 
with greater tension, resulting in the formation of cortical gyri [33]. 
This suggests that patterns of cortical folding reflect cellular morpho-
genesis, which might be impacted by factors from the intra-uterine 
environment. Indeed, abnormal cortical folding patterns have been 
observed in individuals with abnormal neurodevelopmental outcome 
[33–36]. 
Furthermore, in the CHD group of children, we showed an asso-
ciation between a larger baseline size of the left Sylvian fissure and a 
poorer outcome of the CBCL. Multiple studies have shown that prenatal 
brain growth, like TCD, BPD, and HC, can be impaired in children with 
CHD [3,37]. Also fetal brain development, by means of fetal cortical 
folding, is influenced by CHD [6]. Brain and heart development occur 
simultaneously in the human fetus and often share the same morpho-
genetic programs [38]. These related developmental processes have 
many genes, signalling pathways and cell lineages, like the neural crest, 
in common [39]. Therefore, discrepancies in one of these pathways 
could lead to abnormal development of both organs and may conse-
quently cause neurodevelopmental impairment. Moreover, other path-
ways may play a role in the origin of CHD-related brain abnormalities, 
like derangements in haemodynamic mechanisms. These derangement 
of circulatory flow affects many vital organs, whereas the brain is 
especially vulnerable because of the high need of oxygenated blood and 
Table 1 
General characteristics of the study population and the subgroups fetal growth restriction, preterm birth, congenital heart disease and controls.               
FGR 
n = 10 
Missings PTB 
n = 10 
Missings CHD 
n = 12 
Missings Controls 
n = 106 
Missings Total 
n = 138 
Missings p-value  
Maternal characteristics 















Non-Western   
9 (90.0)  
1 (10.0)    
9 (90.0) 
1 (10.0)    
11 (91.7)  
1 (8.3)    
81 (76.4) 
8 (7.5) 
16 (15.1)    
110 (79.7) 
9 (6.5) 








2 (20.0)   
1 (10.0) 
6 (60.0) 
3 (30.0)    
3 (25.0) 
9 (75.0)   
8 (7.5) 
35 (33.0) 
63 (59.4)   
10 (7.2) 
51 (37.0) 














11  0.368a 




2 (20.0)  4 (40.0)  2 (16.7)  34 (32.1)  42 (30.4)   0.541a 
Periconceptional 
use of alcohol2 
2 (20.0) 1 2 (20.0) 1 8 (66.7)  32 (30.2) 1 44 (31.9)  3  0.059a 
Periconceptional 
smoking2 




5 (50.0) 1 8 (80.0) 1 11 (91.7)  70 (69.3) 7 94 (68.1)  9  0.780a  
Neonatal characteristics 
Gestational age at 
birth, weeks1 













1   < 0.001b 
Male gender2 4 (40.0)  5 (50.0)  7 (58.3)  55 (51.9)  71 (51.4)   0.857a  
Child characteristics 












2  0.799b 
Data are presented as median and interquartile range1 or number (n) and percentage (%)2. Significant differences are in bold font. FGR, fetal growth restriction; PTB, 
preterm birth; CHD, congenital heart disease; BMI, body mass index in kilograms/square meter; IVF/ICSI, in vitro fertilization/intra-cytoplasmic sperm injection. 
a Calculated using chi-squared. 
b Calculated using oneway anova. 
c Calculated using Kruskal wallis H.  
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nutrients [7]. Also in FGR a derangement or adaptation in circulatory 
flow can be involved, this is called the ‘brain sparing effect’ due to 
placental insufficiency. This effect refers to the cerebro-placental blood 
flow redistribution causing the same derangements of circulatory flow 
[1,19]. In the FGR subgroup, a larger baseline size of the Sylvian fissure 
corresponds to a poorer outcome of the CBCL. Possibly, a larger base-
line size of the Sylvian fissure in FGR reflects cortical thinning that also 
results in poorer neurodevelopmental outcome. Though this might 
seem contradictory, these results could be explained by FGR impacting 
fetal brain growth in several ways. Firstly, FGR is associated with re-
duced grey matter in specific areas of the brain, including the insular 
region [40]. Secondly, FGR is associated with reduced white matter 
throughout the whole brain [40]. Both the reduced overall white matter 
and the local reduced grey matter in specific areas of the brain might 
result in altered cortical folding and a larger depth of the Sylvian 
fissure. Finally, most importantly for this study, FGR impacts cortical 
folding with accelerated cortical development reaching maturation of 
the Sylvian fissure [1]. So, even though FGR newborns show reduced 
cortical folding compared to newborns born appropriately grown for 
GA, they show a higher sulcation index in comparison with those born 
with similar cortical surface measurements [41]. Hence, in FGR new-
borns the netto result of the impact of general cortical white matter 
thinning, local grey matter thinning and altered gyrification, results in 
deeper fissure measurements of the insula, which is in line with the 
results of this study [2]. 
These brain abnormalities are likely associated with neurological 
deficits and neurodevelopmental delays [19,20]. Moreover, fetuses 
with FGR may experience more stress resulting in higher cortisol levels, 
which may affect gyrification and possibly subsequently neurodeve-
lopmental outcome [42]. 
Table 2 
Fetal brain growth trajectories of the study groups.          
FGR PTB CHD Controls Total p-value 
n = 10 n = 10 n = 12 n = 106 n = 138  
TCD 
RI −0.062 (−0.703–0.165) −0.010 (−0.117–0.218) 0.058 (−0.427–0.326) −0.022 (−0.316–0.387) −0.016 (−0.329–0.316)  0.486a 
RS −0.003 (−0.019–0.003) −0.002 (−0.011–0.002) −0.001 (−0.008–0.014) 0.001 (−0.006–0.008) −0.001 (−0.007–0.007)  0.077a  
CC 
RI −0.785 (−1.829; −0.337) 0.388 (0.148–1.205) −0.281 (−0.473–0.295) 0.113 (−0.271–0.466) 0.095 (−0.374–0.006)  0.001b 
RS −0.011 (−0.027; −0.005) 0.005 (0.002–0.017) −0.004 (−0.007–0.004) 0.002 (−0.004–0.007) 0.001 (−0.005–0.006)   < 0.001a  
HC 
RI −5.599 (−13.279; −3.072) 0.976 (−0.786–4.489) 0.330 (−3.476–4.496) 1.453 (−1.858–4.339) 0.989 (−2.384–4.231)   < 0.001b 
RS −0.061 (−0.120; −0.029) 0.006 (−0.011–0.031) −0.011 (−0.041–0.019) 0.015 (−0.022–0.050) 0.006 (−0.027–0.047)   < 0.001a  
Sylvian fissure left 
RI −0.347 (−0.528–0.024) 0.019 (−0.621–0.330) 0.000 (−0.422–0.431) 0.206 (−0.215–0.561) 0.160 (−0.283–0.496)  0.057b 
RS −0.009 (−0.016–0.004) 0.000 (−0.009–0.005) −0.003 (−0.009–0.004) 0.001 (−0.005–0.009) 0.001 (−0.006–0.007)  0.160b  
Sylvian fissure right 
RI 0.005 (−0.595–0.255) −0.112 (−0.433–0.377) 0.069 (−0.355–0.654) 0.206 (−0.073–0.488) 0.163 (−0.224–0.469)  0.166a 
RS 0.001 (−0.009–0.009) −0.001 (0.004–0.003) 0.001 (−0.006–0.005) 0.003 (−0.003–0.006) 0.001 (−0.006–0.006)  0.262a  
Insula left 
RI −0.146 (−0.275; −0.028) 0.010 (−0.098–0.324) 0.005 (−0.156–0.131) 0.046 (−0.114–0.187) 0.024 (−0.122–0.169)  0.176a 
RS −0.009 (−0.016; −0.001) 0.003 (−0.006–0.009) 0.001 (−0.006–0.005) 0.001 (−0.005–0.006) 0.001 (−0.006–0.006)  0.023a  
Insula right 
RI −0.036 (−0.152–0.045) −0.019 (−0.117–0.052) 0.019 (−0.068–0.055) 0.007 (−0.102–0.133) −0.003 (−0.102–00114)  0.655a 
RS −0.004 (−0.016–0.003) −0.004 (−0.018–0.004) 0.002 (−0.013–0.010) 0.002 (−0.005–0.011) 0.001 (−0.007–0.010)  0.151b  
POF left 
RI −0.693 (−0.874; −0.187) −0.026 (−0.194–0.248) 0.206 (−0.187–0.434) 0.111 (−0.311–0.469) 0.078 (−0.281–0.409)  0.009a 
RS −0.015 (−0.0177; −0.004) 0.000 (−0.005–0.004) 0.003 (−0.003–0.009) 0.002 (−0.006–0.009) 0.001 (−0.006–0.007)  0.005a  
POF right 
RI −0.523 (−1.022; −0.259) 0.142 (−0.023–0.252) 0.293 (−0.275–0.443) 0.041 (−0.359–0.454) 0.057 (−0.355–0.395)  0.007a 
RS −0.019 (−0.037; −0.005) 0.002 (−0.002–0.007) 0.008 (−0.013–0.213) 0.001 (−0.009–0.012) 0.001 (−0.009–0.011)  0.002a 
Data are presented as median and interquartile range. Significant differences are in bold font. FGR, fetal growth restriction; PTB, preterm birth; CHD, congenital heart 
disease; TCD, transcerebellar diameter; CC, corpus callosum; HC, head circumference; POF, parieto-occipital fissure; RI, random intercept (baseline size); RS, random 
slope (growth rate); n, number. 
a Calculated using oneway-ANOVA. 
b Calculated using Kruskall-Wallis H.  
Table 3 
Total development questionnaire outcome scores of the study groups.           
FGR PTB CHD Controls Total Missings p-value 
n = 10 n = 10 n = 12 n = 106 n = 138  
ASQ-3 total 255 (203–270) 260 (210–280) 255 (245–280) 255 (235–279) 255 (234–275)  10  0.571a 
CBCL total 13 (8–33) 26 (9–38) 16 (10−23) 26 (13–38) 22 (13–37)  45  0.281b 
Data are presented as median and interquartile range. FGR, fetal growth restriction; PTB, preterm birth; CHD, congenital heart disease; ASQ-3, Ages and Stages 
Questionnaire-3; CBCL, Child Behaviour Check-list; n, number. 
a Calculated using oneway-ANOVA. 
b Calculated using Kruskall-Wallis H.  
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In contrast an association between steeper growth rate of the left 
Sylvian fissure and a better outcome of the CBCL was found in the CHD 
group. This suggests that faster growth of this fissure in a fetus with 
CHD is associated with better neurodevelopmental outcomes. 
In this study, associations were found between neurodevelopment 
and specifically left or right brain trajectories. Studies have shown that 
left-right asymmetry in cortical folding is a normal developmental 
phenomena prenatally [43]. This phenomena makes it difficult to hy-
pothesize why specifically left or right brain trajectories are associated. 
Further research is needed to evaluate and clarify these left-right dif-
ferences. 
For imaging of the insula and the Sylvian fissure, 2D imaging seems 
to be sufficient. However, for reliable measurement of the depth of the 
sulci, it is necessary to verify whether this is measured in the correct 
unskewed plane, to avoid overestimating lengths. The verification can 
only be done by checking in a different plane. Though experienced 
operators might be able to make accurate measurements by using only 
2D, for optimal reliability of measurements, we recommend, in line 
with other authors, 3D evaluation to check whether the measurement is 
placed in a perfectly straight plane (A-plane) by checking the B- and C- 
plane of the 3D-US sectional planes. 
A powerful strength of this study is its prospective periconceptional 
cohort design with a follow-up until two years of age, the serial precise 
and reliable fetal brain measurements, and the fact that multiple do-
mains of neurodevelopment were evaluated. Two validated ques-
tionnaires (ASQ-3 and CBCL) were used to assess the psychological and 
locomotive development as well as the behavioural development. 
This study has also some limitations. Firstly, reporting bias of par-
ents in questionnaires is always an issue of concern as responses can be 
influenced by social desirable answers. Furthermore, development was 
assessed once at two years of age rather than longitudinally. Data from 
this study should be interpreted with caution because of small sample 
sizes in the subgroups, which made adjustment for confounding im-
possible, therefore the presence of residual confounding cannot be ex-
cluded. Some parents of children with disabilities due to the PTB, FGR 
or CHD and/or abnormal neurodevelopment, declined to participate in 
this study. Therefore, selection bias due to loss of follow-up cannot be 
excluded. 
To our knowledge, this explorative study is the first in associating 
longitudinal measured fetal brain growth and neurodevelopmental 
outcome at two years of age. This study shows an association between 
prenatal brain growth and postnatal developmental outcome. Further 
optimising future research by incorporating objective evaluation of 
child development and long-term follow-up, for example until 12 years 
Table 4 
















TCD n = 9  n = 9  n = 12  n = 96  n = 124  
RI 129.19 (111.71)  0.300 44.77 (81.02)  0.600 −11.27 (31.54)  0.729 5.68 (8.86)  0.523 7.691 (7.832)  0.328 
RS −3333.43 
(4523.53)  
0.494 −462.94 (1909.04)  0.816 0.90 (1041.31)  0.999 −157.95 (488.64)  0.747 −51.896 (371.09)  0.889 
CC n = 8  n = 8  n = 9  n = 80  n = 104  
RI −1404.72 
(983.75)  









0.142 16,860 (19155)  0.382 7585.945 
(16,715.377)  
0.651 
HC n = 9  n = 9  n = 12  n = 96  n = 125  
RI −8.478 (9.559)  0.409 −1.726 (5.810)  0.776 −0.920 (2.00)  0.657 −0.634 (0.759)  0.406 0.354 (0.835)  0.672 
RS 1369.275 
(925.550)  
0.190 36.068 (366.789)  0.925 −116.071 
(215.936)  
0.604 −11.434 (64.601)  0.860 −15.200 (65.949)  0.818 
Sylvian fissure 
left 
n = 8  n = 9  n = 12  n = 96  n = 123  
RI −17.73 (101.95)  0.869 42.98 (63.46)  0.524 −1.57 (16.75)  0.927 1.08 (7.98)  0.893 2.198 (7.206)  0.761 
RS −533.29 
(4034.37)  
0.900 −1778.20 (4445.77)  0.703 −1502.84 
(884.88)  





n = 8  n = 9  n = 12  n = 96  n = 123  
RI −3.66 (62.33)  0.955 −39.83 (59.85)  0.531 −15.92 (19.76)  0.441 3.75 (6.87)  0.587 0.0738 (5.774)  0.990 
RS 1656.56 (3540.88)  0.660 2912.92 (6151.33)  0.653 247.38 (1689.31)  0.887 219.63 (428.27)  0.610 122.966 (388.530)  0.752 
Insula left n = 8  n = 9  n = 12  n = 96  n = 123  
RI −695.76 (467.13)  0.197 10.15 (80.09)  0.903 −60.82 (45.80)  0.217 12.74 (14.55)  0.384 5.2 (13.773)  0.706 
RS 13,651.95 
(8381.30)  







Insula right n = 8  n = 9  n = 12  n = 96  n = 123  
RI 252.95 (12.49)  0.914 402.35 (199.17)  0.090 51.79 (97.19)  0.607 −48.66 (31.20)  0.123 −17.920 (27.788)  0.520 
RS 1075.17 (3204.58)  0.751 −2400.53 (1845.72)  0.241 −430.46 
(1018.86)  
0.683 271.83 (338.63)  0.424 259.156 (289.437)  0.373 
POF left n = 8  n = 9  n = 12  n = 96  n = 121  
RI −282.90 (418.10)  0.536 −124.19 (252.98)  0.641 111.94 (79.09)  0.191 6.14 (26.46)  0.817 6.908 (25.734)  0.789 
RS 14,424.00 
(21,067.00)  







POF right n = 8  n = 9  n = 12  n = 96  n = 123  
RI 332.61 (750.52)  0.681 −23.08 (88.56)  0.803 6.30 (43.19)  0.887 −11.33 (16.74)  0.501 −8.090 (15.368)  0.600 
RS −8312.31 
(20,517.76)  
0.706 250.77 (2610.86)  0.927 168.11 (1294.19)  0.900 636.59 (547.14)  0.248 524.547 (489.018)  0.286 
Data are presented as coefficient (SE) calculated using linear regression models. Data of the control group has been adjusted for on forehand chosen confounders 
(maternal level of education, parity, mode of conception, periconceptional smoking, preconceptional folic acid use, and gender of the infant). Significant differences 
are in bold font. ASQ-3, Ages and Stages Questionnaire-3; FGR, fetal growth restriction; PTB, preterm birth; CHD, congenital heart disease; TCD, transcerebellar 
diameter; CC, corpus callosum; HC, head circumference; POF, parieto-occipital fissure; RI, random intercept (baseline size); RS, random slope (growth rate); ß, beta 
value; SE, standard error; n, number.  
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of age, will yield more in depth understanding of both the pathophy-
siology and clinical implications of this association. To replicate our 
findings at the age of 2 years and to evaluate the impact on longer term 
development, further research is needed with larger sample sizes and 
standardized long-term neurodevelopmental follow-up, including ob-
jective evaluation such as Bayley Scales of Infant and Toddler 
Development III [24]. Also, the addition of prenatal gyrification scoring 
systems and postnatal MRI and resting state functional MRI at 
6 months, 2 years and 10 years would provide valuable information [1]. 
In this study, associations between fetal brain growth and neuro-
development at 2 years of age are investigated. It would also be in-
teresting to study these associations even earlier during pregnancy in 
the embryonic brain. 
In conclusion, this explorative study shows that growth of several 
prenatal brain structures in the second half of pregnancy is associated 
with neurodevelopment at two years of age, as evaluated by ASQ-3 and 
CBCL, in the FGR and CHD subgroups and the control and total groups. 
Further research is needed to confirm these findings and to elucidate 
the underlying pathophysiological mechanisms and clinical implica-
tions. 
Funding 
Department of Obstetrics and Gynaecology, Erasmus MC, and 
Sophia Research Foundation for Medical Research, Rotterdam, The 
Netherlands (SSWO grant number 644). 
CRediT authorship contribution statement 
Mila S. Welling: Conceptualization, Methodology, Software, 
Formal analysis, Investigation, Writing - original draft, Writing - review 
& editing, Visualization, Project administration. Sofie C. Husen: 
Writing - review & editing, Visualization. Attie T.J.I. Go: Writing - 
review & editing. Irene A.L. Groenenberg: Writing - review & editing. 
Sten P. Willemsen: Methodology, Software. Hilmar H. Bijma: 
Conceptualization, Writing - review & editing. Régine P.M. Steegers- 
Theunissen: Conceptualization, Methodology, Writing - review & 
editing, Supervision, Project administration, Funding acquisition. 
Declaration of competing interest 
The authors report no conflict of interest. 
Acknowledgments 
We would like to thank all participating children and their parents, 
the Rotterdam periconception cohort team and the outpatient clinic of 
Obstetrics and Prenatal Medicine at the Erasmus MC, University 
Medical Centre, Rotterdam, The Netherlands, for their contribution to 
the study. We would like to thank dr. Irene V. Koning, who was re-
sponsible for performing and collecting of all ultrasounds measure-
ments. This study was funded by the Department of Obstetrics and 
Gynaecology of the Erasmus MC, University Medical Centre, 
Rotterdam, The Netherlands, and Sophia research foundation for 
Medical Research, Rotterdam, The Netherlands. 
Appendix A. Supplementary data 
Supplementary data to this article can be found online at https:// 
doi.org/10.1016/j.earlhumdev.2020.105224. 
Table 5 















TCD n = 5  n = 6  n = 12  n = 69  n = 91  
RI 5.43 (3.89)  0.298 7.05 (8.03)  0.447 1.09 (1.64)  0.523 −0.87 (0.75)  0.249 −0.779 (0.614)  0.208 
RS −69.35 (143.08)  0.676 −59.27 (174.42)  0.756 −43.24 (54.08)  0.445 −1.77 (39.33)  0.964 5.902 (26.676)  0.825 
CC n = 6  n = 5  n = 9  n = 56  n = 75  
RI −3.99 (29.55)  0.901 −142.39 (44.96)  0.087 −22.72 (80.49)  0.787 14.55 (25.95)  0.578 −2.960(4.734)  0.534 
RS −341.73 (2036.01)  0.877 10,033.08 (3189.02)  0.088 1596.17 (5579.91)  0.784 −1038 (1814)  0.570 230.443 (364.737)  0.530 
HC n = 6  n = 6  n = 12  n = 69  n = 92  
RI 0.119 (0.315)  0.731 0.375 (0.260)  0.245 −0.027 (0.105)  0.805 0.002 (0.084)  0.981 0.037 (0.060)  0.539 
RS 3.420 (32.826)  0.924 −9.499 (22.459)  0.701 12.316 (11.378)  0.307 −10.003 (5.762)  0.088 −8.419 (4.413)  0.060 
Sylvian fissure left n = 6  n = 6  n = 12  n = 69  n = 91  
RI −0.39 (0.71)  0.889 −1.84 (3.54)  0.639 3.11 (0.79)  0.003 0.40 (−0.61)  0.516 0.563 (0.490)  0.254 
RS 155.14 (126.58)  0.308 252.03 (181.06)  0.258 −171.99 (41.86)  0.003 −51.83 (32.3)  0.114 −42.349 (25.960)  0.107 
Sylvian fissure right n = 6  n = 6  n = 12  n = 69  n = 92  
RI 4.13 (0.68)  0.009 0.49 (3.85)  0.907 −1.42 (1.06)  0.213 −0.72 (0.51)  0.163 −0.518 (0.391)  0.189 
RS −104.69 (37.90)  0.070 −5.85 (345.15)  0.988 143.56 (90.37)  0.147 4.79 (31.85)  0.881 21.819 (26.240)  0.408 
Insula left n = 6  n = 6  n = 12  n = 69  n = 91  
RI 5.47 (28.04)  0.858 −7.52 (2.92)  0.082 1.42 (2.68)  0.608 −1.15 (1.15)  0.319 −1.142 (0.859)  0.188 
RS −16.58 (385.90)  0.968 172.66 (82.55)  0.128 2.35 (68.31)  0.973 57.77 (32.94)  0.085 46.411 (23.319)  0.051 
Insula right n = 6  n = 6  n = 12  n = 69  n = 92  
RI −0.38 (19.27)  0.986 −0.02 (11.07)  0.999 −4.33 (5.23)  0.429 3.41 (2.65)  0.204 2.592 (1.973)  0.193 
RS 65.99 (174.02)  0.730 102.78 (118.80)  0.451 50.71 (54.20)  0.374 −24.54 (26.17)  0.352 −10.114 (20.910)  0.630 
POF left n = 6  n = 6  n = 12  n = 69  n = 92  
RI −22.08 (11.01)  0.139 −20.33 (24.59)  0.469 −4.15 (5.30)  0.454 0.25 (2.44)  0.918 0.467 (1.624)  0.775 
RS 1214.84 (561.51)  0.119 1449.42 (1408.86)  0.379 209.30 (259.31)  0.440 −13.45 (126.09)  0.915 −20.834 (83.880)  0.804 
POF right n = 6  n = 6  n = 12  n = 69  n = 92  
RI −24.32 (20.12)  0.313 −4.89 (12.67)  0.725 0.12 (2.55)  0.964 0.85 (1.46)  0.563 0.890 (1.069)  0.408 
RS 689.99 (548.17)  0.297 141.17 (490.94)  0.792 7.33 (76.23)  0.926 −32.22 (48.87)  0.512 −30.592 (34.669)  0.380 
Data are presented as coefficient (SE), calculated using linear regression models. Data of the control group has been adjusted for on forehand chosen confounders 
(maternal level of education, parity, mode of conception, periconceptional smoking, preconceptional folic acid use, and gender of the infant). Significant differences 
are in bold font. CBCL, Child Behaviour Check-list; FGR, fetal growth restriction; PTB, preterm birth; CHD, congenital heart disease; TCD, transcerebellar diameter; 
CC, corpus callosum; HC, head circumference; POF, parieto-occipital fissure; RI, random intercept (baseline size); RS, random slope (growth rate); ß, beta value; SE, 
standard error; n, number.  
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